Peter Bauer Ph.D. President and CEO. Peter has over 25 years of executive management, sales, marketing, and R&D experience in both the implantable and diagnostic
device industries. He most recently served as President of Inovise Medical, after leading as their EVP of R&D from 2003-2009, and various leadership positions at BIOTRONIK from 1995-2003.
Peter began his career in the medical device industry in 1995 after several years in the area of solid-state physics, surface science, and nanotechnology. He holds a Ph.D. in Physics from the University of Erlangen-Nuremberg, Germany.

Ed Chinchoy Ph.D. Executive Vice President of Strategy and Commercialization. Ed’s experience includes over 15 years in various leadership and management positions responsible for global strategy, product management, marketing and R&D at St Jude Medical and Medtronic including in the areas of cardiac rhythm management, heart failure therapy and monitoring.
Ed’s experience includes multinational commercialization of over 20 novel therapies and medical device platforms. He has also served as a business consultant for several fortune 100 health care companies on product management and commercialization. He holds a PhD in BioMedical Engineering from the University of Minnesota.

David A. Chazanovitz. Chairman of the Board. Dave is the Chairman of the Board, most recently serving as the chairman of the board of Inovise Medical, and President and CEO of Alveolus, Inc.
He previously served as President and CEO of Cambridge Heart, Inc. and President of several divisions of C.R. Bard, Inc. In 1995, Mr. Chazanovitz founded Interventions, and served as Division President of NMT Medical, Inc. after the merger of the two companies until 2000. He concurrently serves as Chairman of the Board of MassPro, the Massachusetts quality improvement organization.